HMGB1 as a drug target in staphylococcal pneumonia

Critical Care

Volumn 18, Issue 2, 2014, Pages

  Fink, Mitchell P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; HIGH MOBILITY GROUP B1 PROTEIN; ADVANCED GLYCATION END PRODUCT; IMMUNOGLOBULIN RECEPTOR;

DRUG TARGETING; HUMAN; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN FUNCTION; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS; ANIMAL; LUNG; METABOLISM; PATHOLOGY;

ANIMALS; GLYCOSYLATION END PRODUCTS, ADVANCED; HMGB1 PROTEIN; LUNG; PNEUMONIA, STAPHYLOCOCCAL; RECEPTORS, IMMUNOLOGIC;

EID: 84899129282     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13810     Document Type: Note

References (21)

1. Achouiti A, van der Meer AJ, Florquin S, Yang H, Tracey KJ, Vant Veer C, De Vos AF, Van der Poll T. High-mobility group box 1 and the receptor for advanced glycation end products contribute to lung injury during Staphylococcus aureus pneumonia. Crit Care 2013, 17:R296. 10.1186/cc13162, 24342460.
2. Shooter KV, Goodwin GH, Johns EW. Interactions of a purified non-histone chromosomal protein with DNA and histone. Eur J Biochem 1974, 47:263-270. 10.1111/j.1432-1033.1974.tb03690.x, 4472153.
3. Wang H, Bloom O, Zhang M, Vishnubhakat JM, Ombrellino M, Che J, Frazier A, Yang H, Ivanova S, Borovikova L, Manogue KR, Faist E, Abraham E, Andersson J, Andersson U, Molina PE, Abumrad NN, Sama A, Tracey KJ. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999, 285:248-251. 10.1126/science.285.5425.248, 10398600.
4. Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends Immunol 2007, 28:429-436. 10.1016/j.it.2007.08.004, 17845865.
5. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol 2005, 5:331-342. 10.1038/nri1594, 15803152.
6. Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F, Liu J, Antonelli A, Preti A, Raeli L, Shams SS, Yang H, Varani L, Andersson U, Tracey KJ, Bachi A, Uguccioni M, Bianchi ME. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med 2012, 209:1519-1528. 10.1084/jem.20120189, 3428943, 22869893.
7. Yang H, Lundbäck P, Ottosson L, Erlandsson-Harris H, Venereau E, Bianchi ME, Al-Abed Y, Andersson U, Tracey KJ, Antoine DJ. Redox modification of cysteine residues regulates the cytokine activity of high mobility group box-1 (HMGB1). Mol Med 2012, 18:250-259. 3324950, 22105604.
8. Schiraldi M, Raucci A, Muñoz LM, Livoti E, Celona B, Venereau E, Apuzzo T, De Marchis F, Pedotti M, Bachi A, Thelen M, Varani L, Mellado M, Proudfoot A, Bianchi ME, Uguccioni M. HMGB1 promotes recruitment of inflammatory cells to damaged tissues by forming a complex with CXCL12 and signaling via CXCR4. J Exp Med 2012, 209:551-563. 10.1084/jem.20111739, 3302219, 22370717.
9. Yang H, Ochani M, Li J, Qiang X, Tanovic M, Harris HE, Susarla SM, Ulloa L, Wang H, DiRaimo R, Czura CJ, Wang H, Roth J, Warren HS, Fink MP, Fenton MJ, Andersson U, Tracey KJ. Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A 2004, 101:296-301. 10.1073/pnas.2434651100, 314179, 14695889.
10. Yang R, Harada T, Mollen KP, Prince JM, Levy RM, Englert JA, Gallowitsch-Puerta M, Yang L, Yang H, Tracey KJ, Harbrecht BG, Billiar TR, Fink MP. Anti-HMGB1 neutralizing antibody ameliorates gut barrier dysfunction and improves survival after hemorrhagic shock. Mol Med 2006, 12:105-114. 1578769, 16953558.
11. Abraham E, Arcaroli J, Carmody A, Wang H, Tracey KJ. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000, 165:2950-2954.
12. Fink MP. Bench-to-bedside review: High-mobility group box 1 and critical illness. Crit Care 2007, 11:229. 10.1186/cc6088, 2556731, 17903310.
13. Ueno H, Matsuda T, Hashimoto S, Amaya F, Kitamura Y, Tanaka M, Kobayashi A, Maruyama I, Yamada S, Hasegawa N, Soejima J, Koh H, Ishizaka A. Contributions of high mobility group box protein in experimental and clinical acute lung injury. Am J Respir Crit Care Med 2004, 170:1310-1316. 10.1164/rccm.200402-188OC, 15374839.
14. Goldstein RS, Bruchfeld A, Yang L, Qureshi AR, Gallowitsch-Puerta M, Patel NB, Huston BJ, Chavan S, Rosas-Ballina M, Gregersen PK, Czura CJ, Sloan RP, Sama AE, Tracey KJ. Cholinergic anti-inflammatory pathway activity and High mobility group box-1 (HMGB1) serum levels in patients with rheumatoid arthritis. Mol Med 2007, 13:210-215. 1899837, 17597834.
15. Taniguchi N, Kawahara K, Yone K, Hashiguchi T, Yamakuchi M, Goto M, Inoue K, Yamada S, Ijiri K, Matsunaga S, Nakajima T, Komiya S, Maruyama I. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. Arthritis Rheum 2003, 48:971-981. 10.1002/art.10859, 12687539.
16. Fink MP. Animal models of sepsis. Virulence 2013, 5:143-153. 3916368, 24022070.
17. Seok J, Warren HS, Cuenca AG, Mindrinos MN, Baker HV, Xu W, Richards DR, McDonald-Smith GP, Gao H, Hennessy L, Finnerty CC, López CM, Honari S, Moore EE, Minei JP, Cuschieri J, Bankey PE, Johnson JL, Sperry J, Nathens AB, Billiar TR, West MA, Jeschke MG, Klein MB, Gamelli RL, Gibran NS, Brownstein BH, Miller-Graziano C, Calvano SE, Mason PH, et al. Genomic responses in mouse models poorly mimic human inflammatory diseases. Proc Natl Acad Sci U S A 2013, 110:3507-3512. 10.1073/pnas.1222878110, 3587220, 23401516.
18. Karp CL. Unstressing intemperate models: how cold stress undermines mouse modeling. J Exp Med 2012, 209:1069-1074. 10.1084/jem.20120988, 3371737, 22665703.
19. Rehberg S, Yamamoto Y, Sousse L, Bartha E, Jonkam C, Hasselbach AK, Traber LD, Cox RA, Westphal M, Enkhbaatar P, Traber DL. Selective V(1a) agonism attenuates vascular dysfunction and fluid accumulation in ovine severe sepsis. Am J Physiol Heart Circ Physiol 2012, 303:H1245-H1254. 10.1152/ajpheart.00390.2012, 3517638, 22961865.
20. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, Albrecht V, Limbago B, Talan DA, EMERGEncy ID NET Study Group Prevalence of methicillin-resistant staphylococcus aureus as an etiology of community-acquired pneumonia. Clin Infect Dis 2012, 54:1126-1133. EMERGEncy ID NET Study Group.
21. Tadros M, Williams V, Coleman BL, McGeer AJ, Haider S, Lee C, Iacovides H, Rubinstein E, John M, Johnston L, McNeil S, Katz K, Laffin N, Suh KN, Powis J, Smith S, Taylor G, Watt C, Simor AE. Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals. PLoS One 2013, 8:e75171. 10.1371/journal.pone.0075171, 3775759, 24069391.